Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells

Cancer Research

Volumn 57, Issue 19, 1997, Pages 4348-4355

  Salazar Onfray, Flavio ^a   Nakazawa, Tsutomu ^a   Chhajlani, Vijay ^b,c   Petersson, Max ^a   Kärre, Klas ^a   Masucci, Giuseppe ^d   Celis, Esteban ^e   Sette, Alessandro ^e   Southwood, Scott ^e   Appella, Ettore ^f   Kiessling, Rolf ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e CYTEL CORPORATION   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; INTERMEDIN; SYNTHETIC PEPTIDE;

ADRENAL FUNCTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MELANOMA CELL; MOLECULAR CLONING; MONONUCLEAR CELL; MULTIGENE FAMILY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; AUTOIMMUNITY; COS CELLS; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY; MELANOMA; PEPTIDE FRAGMENTS; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0030804305     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., de Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
2. Gaugler, B., van den Eynde, B., Van der Bruggen, P., Romero, P., Gaforio, J. J., de Plaen, E., Lethé, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
3. Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., de Plaen, E., Hankeln, T., Meyer zum Buschenfelde, K. H., and Beach, D. A p16INK4a-intensive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1284, 1995.
4. Coulie, P. G., Brichard, V., Van Peal, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J-P., Renault, J-P., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
5. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458-6462, 1994.
6. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
7. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene coded for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2+ melanoma. J. Exp. Med., 178: 489-495, 1993.
8. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J., Appella, E., and Rosenberg, S. A., Identification of the immunodominant peptides of the Mart-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
9. Kawakami, Y., Eliyahu, S., Jennings, C. Sakaguchi, K., Kang, X., Southwood, S., Robbins, P., Sette, A., Appella, E., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol., 154: 3961-3968, 1995.
10. Varaa, J. M., Saper, M. A., Lerner, A. B., and Fritsch, P. Non-random distribution of receptors for melanocyte-stimulating hormone on the surface of mouse melanoma cells. J. Supramol. Struct., 4: 45-49, 1976.
11. Halaban, R., Pomerantz, S. H., Marshall, S., Lambert, D. T., and Lerner, A. B. Regulation of tyrosinase in human melanocytes grown in culture. J. Cell Biol., 97: 480-488, 1983.
12. Bennett, D. C. Mechanisms of differentiation in melanoma cells and melanocytes. Environ. Health Perspect., 80: 49-59, 1989.
13. Kameyama, K., Jimenez, M., Muller, J., Ishida, Y., and Hearing, V. J. Regulation of mammalian melanogenesis by tyrosinase inhibition. Differentiation, 42: 28-36, 1989.
14. Lunec, J., Pieron, C., and Thody, A. J. MSH receptor expression and relationship to the melanogenesis and metastatic activity in B16 melanoma. Melanoma Res., 2: 5-12, 1992.
15. Bennett, D. C., Holmes, A., Devlin, L., and Hart, I. R. Experimental metastasis and differentiation of murine melanoma cells: actions and interactions of factors affecting different intracellular signalling pathways. Clin. Exp. Metastasis, 12: 385-397, 1994.
16. MacNeil, S., Buffey, J., Hill, S. E., Dobson, J., and Bleehen, S. S. MSH increases intracellular calcium in melanoma cells. Br. J. Dermatol., 123: 828-834, 1990.
17. Buffey, J., Thody, A. J., Bleehen, S. S., and MacNeil, S. Alpha-melanocyte stimulating hormone stimulates protein kinase C activity in murine B16 melanoma. J. Endocrinol., 133: 333-340, 1992.
18. Xia, Y., Muceniece, R., and Wikberg, J. E. S. Immunological localisation of melanocortin 1 receptor on the cell surface of WM266-4 human melanoma cells. Cancer Lett., 98: 157-162, 1996.
19. Chhajlani, V., and Wikberg, J. E. S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS, 309: 417-420, 1992.
20. Tatro, J. B., Atkins, M., Mier, J. W., Hardarson, S., Wolfe, H., Smith, T., Entwistle, M. L., and Reichlin, S. Melanotropin receptors demonstrated in situ in human melanoma. J. Clin. Invest., 85: 1825-1832, 1990.
21. Ghanem, G., Verstegen, J., Libert, A., Arnould, R., and Lejeune, F. Alpha-melanocyte-stimulating hormone immunoreactivity in human melanoma metastases extracts. Pigment Cell Res., 2: 519-523, 1989.
22. Mountjoy. K., Robbins, L., Mortrud, M., and Cone, R. The cloning of a family of genes that encode the melanotropin receptor. Science (Washington DC), 257: 1248-1251, 1992.
23. Chhajlani, V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem. Mol. Biol. Int., 38: 73-77, 1996.
24. Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S. J., DelValle, J., and Yamada, T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem., 268: 8246-8250, 1993.
25. Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S. J., DelValle, J., and Yamada, T. Molecular cloning, expression, and gene localisation of a fourth melanocortin receptor. J. Biol. Chem., 268: 15174-15179, 1993.
26. Chhajlani, V., Muceniece, R., and Wikberg, J. E. Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun., 195: 866-873, 1993.
27. Gulukota, K., Sidney, J., Sette, A., and DeLisi, C. Two complementary methods for predicting peptides binding to major histocompatibility complex molecules. J. Mol. Biol., 267: 1258-1267, 1997.
28. Sette, A., Sidney, J., del Guercio, M., Southwood, S., Ruppert, J., Dahlberg, C., Grey, H., and Kubo, R. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assay. Mol. Immunol., 31: 813-822, 1994.
29. Salter, R., and Cresswell, P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB hybrid. EMBO J., 5: 943-949, 1986.
30. Zemmour, J., Little, A. M., Sehendel, J., and Parham, P. The HLA-A.B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol., 148: 1941-1948, 1992.
31. Hansen, M. B., Nielsen, S. E., and Berk, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119: 203-210, 1989.
32. Rivoltini, L., Loftus, D. J., Barracchini, K., Arienti, F., Mazzocchi, A., Biddison, W. E., Salgaller, M. L., Appella, E., Parmiani, G., and Marincola, F. M. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. J. Immunol., 156: 3882-3891, 1996.
33. Mazzocchi, A., Storkus, W. J., Traversan, C., Tarsini, P., Maeurer, M. J., Rivoltini, L., Vegetti, C., Belli, F., Anichini, A., Parmiani, B., and Castelli, C. Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTL and shared by melanomas but not melanocytes. J. Immunol., 157: 3030-3038, 1996.
34. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slingluff, C. L. Identification of a peptide recognized by five melanoma specific human cytotoxic T-cell lines. Science (Washington DC), 264: 716-719, 1994.
35. Nijman, H. W., van der Burg, S. H., Vierboom, M. P., Houbiers, J. G., Kast, W. M., and Melief, C. J. p53, a potential target for tumor-directed T cells. Immunol. Lett., 40: 171-178, 1994.
36. Fisk, B., Blevins, T. L., Wharton, J. T., and Ioannides, C. G. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J. Exp. Med., 181: 2109-2117, 1995.
37. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, J. Allele-specific motif revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.), 351: 290-296, 1991.
38. Parker, K., Bednarek, M., Hull, L., Utz, U., Cunningham, B., Zweering, J., Biddison, W., and Coligan, J. Sequence motifs important for peptide binding to the human MHC class I molecule. HLA-A2. J. Immunol., 149: 3580-3587, 1992.
39. Kubo, R. T., Sette, A., Grey, H. M., Appella, E., Sakaguchi, K., Zhu, N. Z., Arnott, D., Sherman, N., Shabanowitz, J., Michel, H., Bodnar, W. M., Davis, T. A., and Hunt, D. F. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol., 152: 3913-3924, 1994.
40. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., Sidney, I., Del Guercio, M-F., Southwood, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., and Chisari, F. V. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol., 153: 5586-5592, 1994.
41. Salgaller, M. L., Weber, J. S., Koenig, S., Yannelli, J. R., and Rosenberg, S. A. Generation of specific anti-MAGE1 reactivity by stimulation of human tumor infiltrating lymphocytes with MAGE1 synthetic peptide. Cancer Immunol. Immunother., 39: 105-116, 1994.
42. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154: 2257-2265, 1995.
43. Van Elsas, A., Nijman, H. W., Van der Minne, C. E., Mourer, J. S., Kast, W. M., Melief, C. J. M., and Schrier, P. I. Induction and characterisation of cytotoxic T-lymphocytes recognising a mutated p21 RAS peptide presented by HLA-A2010. Int. J. Cancer, 61: 389-396, 1995.
44. Houbiers, J. G. A., Nijman, H. W., van der Burg, S. H., Drijfhout, J. W., Kenemans, P., van de Velde, C. J. H., Brand, A., Momberg, F., Kast, W. M., and Melief, C. J. M., In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur. J. Immunol., 23: 2072-2077, 1993.